Related Experiment Video

Updated: Oct 1, 2026

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
07:52

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department

Published on: January 29, 2011

[Decompensation in chronic respiratory insufficiency in children]

M C Lelong-Tissier1, I Claudet

  • 1SMUR pédiatrique, SAMU 31, hôpital des Enfants, CHU de Toulouse, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|May 4, 2000
PubMed

Insights

Noninvasive ventilation helps manage acute exacerbations of chronic obstructive pulmonary disease and neuromuscular disorders, potentially avoiding endotracheal intubation. This method, often using a nasal mask, offers an alternative to traditional mechanical ventilation.

Area of Science:

  • Pulmonology
  • Critical Care Medicine

Context:

  • Acute exacerbations of chronic obstructive pulmonary disease (COPD) and restrictive lung diseases present significant management challenges.
  • Bronchopulmonary dysplasia, characterized by bronchial hyperreactivity, is a key obstructive pathology requiring ventilatory support.

Purpose:

  • To explore the utility of noninvasive ventilation (NIV) in managing acute respiratory failure.
  • To evaluate NIV as an alternative to endotracheal intubation and its associated complications.

Summary:

  • Noninvasive ventilation can be employed in acute exacerbations of COPD and restrictive pulmonary diseases to prevent endotracheal intubation.
  • NIV, potentially administered via a nasal mask, is indicated for conditions like bronchopulmonary dysplasia and neuromuscular disorders with hypoventilation and hypercarbia.

Impact:

  • Provides a less invasive approach to respiratory support, potentially reducing patient morbidity.
  • Expands ventilatory management options for patients with complex pulmonary and neuromuscular conditions.

More Related Videos

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)

Published on: April 7, 2021

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...